GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanix Biotechnologies AG (FRA:ELN) » Definitions » Pretax Margin %

Elanix Biotechnologies AG (FRA:ELN) Pretax Margin % : -2,087.50% (As of Dec. 2018)


View and export this data going back to . Start your Free Trial

What is Elanix Biotechnologies AG Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Elanix Biotechnologies AG's Pre-Tax Income for the six months ended in Dec. 2018 was €-0.67 Mil. Elanix Biotechnologies AG's Revenue for the six months ended in Dec. 2018 was €0.03 Mil. Therefore, Elanix Biotechnologies AG's pretax margin for the quarter that ended in Dec. 2018 was -2,087.50%.

The historical rank and industry rank for Elanix Biotechnologies AG's Pretax Margin % or its related term are showing as below:


FRA:ELN's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.22
* Ranked among companies with meaningful Pretax Margin % only.

Elanix Biotechnologies AG Pretax Margin % Historical Data

The historical data trend for Elanix Biotechnologies AG's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elanix Biotechnologies AG Pretax Margin % Chart

Elanix Biotechnologies AG Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -39,100.00 -1,545.81 -5,577.42

Elanix Biotechnologies AG Semi-Annual Data
Dec08 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23,433.33 -2,629.49 -978.52 -9,296.67 -2,087.50

Competitive Comparison of Elanix Biotechnologies AG's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elanix Biotechnologies AG's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's Pretax Margin % falls into.



Elanix Biotechnologies AG Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Elanix Biotechnologies AG's Pretax Margin for the fiscal year that ended in Dec. 2018 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2018 )/Revenue (A: Dec. 2018 )
=-3.458/0.062
=-5,577.42 %

Elanix Biotechnologies AG's Pretax Margin for the quarter that ended in Dec. 2018 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2018 )/Revenue (Q: Dec. 2018 )
=-0.668/0.032
=-2,087.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elanix Biotechnologies AG  (FRA:ELN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Elanix Biotechnologies AG Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Elanix Biotechnologies AG (FRA:ELN) Business Description

Traded in Other Exchanges
N/A
Address
Street-4, Georg-Glock, c/o HEUKING KÜHN LÜER WOJTEK, Dusseldorf, NW, DEU, 40474
Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.

Elanix Biotechnologies AG (FRA:ELN) Headlines

No Headlines